Navigation Links
Ceres Announces Webcast of Fiscal Year 2013 Financial Results
Date:11/14/2013

THOUSAND OAKS, Calif., Nov. 14, 2013 /PRNewswire/ -- Energy crop company Ceres, Inc. (Nasdaq: CERE) today announced that it will report financial results for fiscal year 2013 on Thursday, November 21, 2013 after the close of the market. The company has scheduled a webcast and conference call for 4:30 p.m. EST (1:30 p.m. PST) to discuss its fiscal year-end results and to provide an update on its business.

Live audio of the conference call will be webcast over the Internet and will be available to investors, members of the news media and the general public. To access the webcast of the conference call, go to investor.ceres.net. Audio of the teleconference is also available by dialing:

North America callers:
(877) 838-4153

International callers:
+1 (720) 545-0037

An audio replay of the call will be available approximately two hours after the conclusion of the live call, and remain available on the Ceres website for 30 days.

ABOUT CERES
Ceres, Inc. is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.


'/>"/>
SOURCE Ceres, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
2. Ceres Receives $3.5 million from USAID for Trait Stacks
3. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
6. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
7. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
8. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
9. WuXi PharmaTech Announces Third-Quarter 2011 Results
10. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
11. Spherix Announces Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... JERUSALEM , May 26, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has submitted the study protocol for the company,s ... to the U.S. Food and Drug Administration (FDA). The ... Drug (IND) application. The Phase IIb study ...
(Date:5/26/2015)... Fluorinov Pharma (Fluorinov), a FACIT portfolio company, today announced ... its Board of Directors.  His appointment strengthens Fluorinov,s leadership ... accelerates its clinical development activities.  "On ... to welcome Luke to the Board of Directors.  Luke ... strength and success of multiple organizations," said Malik ...
(Date:5/26/2015)... Ill. , May 26, 2015  AbbVie ... announced today that it has completed the acquisition ... presence in oncology. Pharmacyclics is a leader in ... first-in-class BTK-inhibitor used to treat hematological cancers, a ... shared expertise, combined with AbbVie,s broad late-stage oncology ...
(Date:5/26/2015)... YORK , May 26, 2015 US-Australian drug discovery ... today that it will present at the 2015 Marcum MicroCap ... York City at the Grand Hyatt Hotel. ... Chairman and CEO, is scheduled to begin at 9.30 a.m. ET ... webcast, go to http://wsw.com/webcast/marcum3/nvgn . The annual ...
Breaking Biology Technology:Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 2Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 3AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4
... Anesiva,Inc. (Nasdaq: ANSV ) announced today that John ... BioCentury,s Newsmakers in the,Biotech Industry Conference in New York ... To access the live webcast or the subsequent archived ... Investors page, and click on Events.,Please connect to Anesiva,s ...
... Aug. 30 Verenium,Corporation (Nasdaq: VRNM ), a ... the development of high-performance specialty,enzymes, announced today that Carlos ... be presenting at the Cowen and Company Clean,Energy Conference. ... ET,on Thursday, September 6, 2007 and will take place ...
... steps ... towards public reporting status., SAN ANTONIO, Aug. 30 ... targeted cancer therapies with improved efficacy and reduced toxicity,announced the ... a control position in a public reporting shell company. ...
Cached Biology Technology:Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 3OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company 2
(Date:5/19/2015)... 2015  Technology is rapidly advancing, outpacing enterprises, ability ... cloud. Passwords and their management are soon to be ... specifications such as those developed by the FIDO Alliance™. ... presents for BYOD, COPE, IoT, and mobile payments, the ... In response to the call for ...
(Date:5/14/2015)... 2015  Verificient Technologies, Inc., a technology ... remote proctoring, announced a new alliance partnership ... creator of the Canvas Learning Management System ... will benefit from the seamless integration of ... a fully integrated multifactor biometrics behavioral application, ...
(Date:5/10/2015)... -- Fingerprint Cards (FPC) has received an order ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... in China . The order value of ... + 1 000 MSEK for 2015.   Jörgen Lantto, ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... specialist in stem cell biology at the University at ... Institutes of Health to investigate the potential of bone ... malfunction known as hibernating myocardium. , Hibernating myocardium is ... reduced blood flow over an extended period of time ...
... new national health study funded by the NH&MRC, industry ... Institute in Melbourne shows diabetes is hitting up to ... findings of the Australian Diabetes, Obesity and Lifestyle Study ... Health and Ageing, Mr Tony Abbott and provide the ...
... dose of radiation lost up to 39% of the ... bone's weight bearing connections by up to 64%, researchers ... of the Journal of Applied Physiology, has implications for ... space flights. , "We were really surprised at the ...
Cached Biology News:Adult stem cell research at UB targets damaged hearts 2Diabetes hits 275 Australians each day as pandemic spreads 2Diabetes hits 275 Australians each day as pandemic spreads 3One therapeutic dose of radiation causes 30 percent spongy bone loss in mice 2One therapeutic dose of radiation causes 30 percent spongy bone loss in mice 3
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
RABBIT ANTI HUMAN ATR (aa2122-2380) Immunogen: Human ATR peptide, amino acids 2122-2380...
GOAT ANTI FRK...
UV LAMP 254 NM 8 WATT, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: